Whalesbook
Record Dividend aur Strong Results Ki Khabar!
Arre yaar, Abbott India ne toh kamaal hi kar diya! Investors ke liye ekdum record-breaking khabar hai – company ne highest-ever dividend announce kiya hai, jo hai ₹656 per share! Poora FY26 ka hisab-kitaab jab dekha toh revenue 8.1% badhkar ₹6,929.05 crore ho gaya, aur net profit bhi 9.7% jump karke ₹1,552.02 crore par pahunch gaya. Q4 mein bhi performance acchi rahi, revenue 6.5% aur profit 7.6% up raha.
Par Stock Price Phir Bhi Neeche Kyun?
Ab yeh sab positive numbers aur record dividend ke baad bhi, stock price 2% neeche gir gaya aur ₹27,240.00 par aa gaya. Yeh hua Tuesday ko jab poora market bhi thoda down tha, Nifty 50 bhi 0.85% neeche tha. Kuch experts ka kehna hai ki shayad log profit booking kar rahe hain ya phir market ki nazrein future growth par zyada hain.
Valuation Aur Dusri Companies Se Comparison
Agar valuation ki baat karein toh Abbott India ka TTM P/E ratio lagbhag 37.08 hai, jo pharma industry ke average 34.5 se thoda upar hai. Yeh Dr. Reddy's Laboratories (around 17.5) aur Cipla (23.5) se toh zyada hai, lekin Sun Pharma (40.9) ke aas-paas hai. Haan, dividend yield 1.78% kaafi accha hai, industry average se double se bhi zyada, jo shareholders ke liye ek accha return hai.
Growth Ki Chinta Aur Analyst Ka Verdict
Company ka balance sheet debt-free hai aur ROE/ROCE bhi strong hai (around 34.5% & 44.9%). Lekin pichle 5 saal mein sales growth average 9.96% rahi hai, jo shayad market ko thodi kam lag rahi hogi. Isi wajah se shayad stock mehnga lag raha hai investors ko. Analysts abhi bhi positive hain, mostly 'Buy' rating de rahe hain aur price target ₹32,000 se ₹35,000 ke beech expect kar rahe hain. Toh income chahiye wale investors ko toh yeh dividend appeal karega, par stock ko aur upar jaane ke liye growth dikhani padegi.